Pre-clinical data indicate that KDM6A variants are associated with a worse survival in AML, possibly because of repressive H3K27me3 marks, which silence genes critical for hematopoietic differentiation [3,4,5]. The gene discussed is KDM6A; the disease is acute myeloid leukemia.